MicroRNA let-7, T cells, and patient survival in colorectal cancer

Ruoxu Dou, Reiko Nishihara, Yin Cao, Tsuyoshi Hamada, Kosuke Mima, Atsuhiro Masuda, Yohei Masugi, Yan Shi, Mancang Gu, Wanwan Li, Annacarolina Da Silva, Katsuhiko Nosho, Xuehong Zhang, Jeffrey A. Meyerhardt, Edward L. Giovannucci, Andrew T. Chan, Charles S. Fuchs, Zhi Rong Qian, Shuji Ogino

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Experimental evidence suggests that the let-7 family of noncoding RNAs suppresses adaptive immune responses, contributing to immune evasion by the tumor. We hypothesized that the amount of let-7a and let-7b expression in colorectal carcinoma might be associated with limited T-lymphocyte infiltrates in the tumor microenvironment and worse clinical outcome. Utilizing the molecular pathological epidemiology resources of 795 rectal and colon cancers in two U.S.-nationwide prospective cohort studies, we measured tumor-associated let-7a and let-7b expression levels by quantitative reverse-transcription PCR, and CD3+, CD8+, CD45RO (PTPRC)+, and FOXP3+ cell densities by tumor tissue microarray immunohistochemistry and computer-assisted image analysis. Logistic regression analysis and Cox proportional hazards regression were used to assess associations of let-7a (and let-7b) expression (quartile predictor variables) with T-cell densities (binary outcome variables) and mortality, respectively, controlling for tumor molecular features, including microsatellite instability, CpG island methylator phenotype, LINE-1 methylation, and KRAS, BRAF, and PIK3CA mutations. Compared with cases in the lowest quartile of let-7a expression, those in the highest quartile were associated with lower densities of CD3+ [multivariate odds ratio (OR), 0.40; 95% confidence interval (CI), 0.23-0.67; Ptrend = 0.003] and CD45RO+ cells (multivariate OR, 0.31; 95% CI, 0.17-0.58; Ptrend = 0.0004), and higher colorectal cancer-specific mortality (multivariate hazard ratio, 1.82; 95% CI, 1.42-3.13; Ptrend = 0.001). In contrast, let-7b expression was not significantly associated with T-cell density or colorectal cancer prognosis. Our data support the role of let-7a in suppressing antitumor immunity in colorectal cancer and suggest let-7a as a potential target of immunotherapy.

Original languageEnglish
Pages (from-to)927-935
Number of pages9
JournalCancer immunology research
Volume4
Issue number11
DOIs
Publication statusPublished - 2016 Nov 1
Externally publishedYes

Fingerprint

MicroRNAs
Colorectal Neoplasms
Cell Survival
T-Lymphocytes
Cell Count
Confidence Intervals
Odds Ratio
Tumor Escape
Neoplasms
Untranslated RNA
Microsatellite Instability
CpG Islands
Tumor Microenvironment
Computer-Assisted Image Processing
Molecular Epidemiology
Mortality
Adaptive Immunity
Rectal Neoplasms
Immunotherapy
Colonic Neoplasms

ASJC Scopus subject areas

  • Immunology
  • Cancer Research

Cite this

Dou, R., Nishihara, R., Cao, Y., Hamada, T., Mima, K., Masuda, A., ... Ogino, S. (2016). MicroRNA let-7, T cells, and patient survival in colorectal cancer. Cancer immunology research, 4(11), 927-935. https://doi.org/10.1158/2326-6066.CIR-16-0112

MicroRNA let-7, T cells, and patient survival in colorectal cancer. / Dou, Ruoxu; Nishihara, Reiko; Cao, Yin; Hamada, Tsuyoshi; Mima, Kosuke; Masuda, Atsuhiro; Masugi, Yohei; Shi, Yan; Gu, Mancang; Li, Wanwan; Da Silva, Annacarolina; Nosho, Katsuhiko; Zhang, Xuehong; Meyerhardt, Jeffrey A.; Giovannucci, Edward L.; Chan, Andrew T.; Fuchs, Charles S.; Qian, Zhi Rong; Ogino, Shuji.

In: Cancer immunology research, Vol. 4, No. 11, 01.11.2016, p. 927-935.

Research output: Contribution to journalArticle

Dou, R, Nishihara, R, Cao, Y, Hamada, T, Mima, K, Masuda, A, Masugi, Y, Shi, Y, Gu, M, Li, W, Da Silva, A, Nosho, K, Zhang, X, Meyerhardt, JA, Giovannucci, EL, Chan, AT, Fuchs, CS, Qian, ZR & Ogino, S 2016, 'MicroRNA let-7, T cells, and patient survival in colorectal cancer', Cancer immunology research, vol. 4, no. 11, pp. 927-935. https://doi.org/10.1158/2326-6066.CIR-16-0112
Dou, Ruoxu ; Nishihara, Reiko ; Cao, Yin ; Hamada, Tsuyoshi ; Mima, Kosuke ; Masuda, Atsuhiro ; Masugi, Yohei ; Shi, Yan ; Gu, Mancang ; Li, Wanwan ; Da Silva, Annacarolina ; Nosho, Katsuhiko ; Zhang, Xuehong ; Meyerhardt, Jeffrey A. ; Giovannucci, Edward L. ; Chan, Andrew T. ; Fuchs, Charles S. ; Qian, Zhi Rong ; Ogino, Shuji. / MicroRNA let-7, T cells, and patient survival in colorectal cancer. In: Cancer immunology research. 2016 ; Vol. 4, No. 11. pp. 927-935.
@article{bf594d68d74e43698b0ce34d26c8cfd8,
title = "MicroRNA let-7, T cells, and patient survival in colorectal cancer",
abstract = "Experimental evidence suggests that the let-7 family of noncoding RNAs suppresses adaptive immune responses, contributing to immune evasion by the tumor. We hypothesized that the amount of let-7a and let-7b expression in colorectal carcinoma might be associated with limited T-lymphocyte infiltrates in the tumor microenvironment and worse clinical outcome. Utilizing the molecular pathological epidemiology resources of 795 rectal and colon cancers in two U.S.-nationwide prospective cohort studies, we measured tumor-associated let-7a and let-7b expression levels by quantitative reverse-transcription PCR, and CD3+, CD8+, CD45RO (PTPRC)+, and FOXP3+ cell densities by tumor tissue microarray immunohistochemistry and computer-assisted image analysis. Logistic regression analysis and Cox proportional hazards regression were used to assess associations of let-7a (and let-7b) expression (quartile predictor variables) with T-cell densities (binary outcome variables) and mortality, respectively, controlling for tumor molecular features, including microsatellite instability, CpG island methylator phenotype, LINE-1 methylation, and KRAS, BRAF, and PIK3CA mutations. Compared with cases in the lowest quartile of let-7a expression, those in the highest quartile were associated with lower densities of CD3+ [multivariate odds ratio (OR), 0.40; 95{\%} confidence interval (CI), 0.23-0.67; Ptrend = 0.003] and CD45RO+ cells (multivariate OR, 0.31; 95{\%} CI, 0.17-0.58; Ptrend = 0.0004), and higher colorectal cancer-specific mortality (multivariate hazard ratio, 1.82; 95{\%} CI, 1.42-3.13; Ptrend = 0.001). In contrast, let-7b expression was not significantly associated with T-cell density or colorectal cancer prognosis. Our data support the role of let-7a in suppressing antitumor immunity in colorectal cancer and suggest let-7a as a potential target of immunotherapy.",
author = "Ruoxu Dou and Reiko Nishihara and Yin Cao and Tsuyoshi Hamada and Kosuke Mima and Atsuhiro Masuda and Yohei Masugi and Yan Shi and Mancang Gu and Wanwan Li and {Da Silva}, Annacarolina and Katsuhiko Nosho and Xuehong Zhang and Meyerhardt, {Jeffrey A.} and Giovannucci, {Edward L.} and Chan, {Andrew T.} and Fuchs, {Charles S.} and Qian, {Zhi Rong} and Shuji Ogino",
year = "2016",
month = "11",
day = "1",
doi = "10.1158/2326-6066.CIR-16-0112",
language = "English",
volume = "4",
pages = "927--935",
journal = "Cancer immunology research",
issn = "2326-6066",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - MicroRNA let-7, T cells, and patient survival in colorectal cancer

AU - Dou, Ruoxu

AU - Nishihara, Reiko

AU - Cao, Yin

AU - Hamada, Tsuyoshi

AU - Mima, Kosuke

AU - Masuda, Atsuhiro

AU - Masugi, Yohei

AU - Shi, Yan

AU - Gu, Mancang

AU - Li, Wanwan

AU - Da Silva, Annacarolina

AU - Nosho, Katsuhiko

AU - Zhang, Xuehong

AU - Meyerhardt, Jeffrey A.

AU - Giovannucci, Edward L.

AU - Chan, Andrew T.

AU - Fuchs, Charles S.

AU - Qian, Zhi Rong

AU - Ogino, Shuji

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Experimental evidence suggests that the let-7 family of noncoding RNAs suppresses adaptive immune responses, contributing to immune evasion by the tumor. We hypothesized that the amount of let-7a and let-7b expression in colorectal carcinoma might be associated with limited T-lymphocyte infiltrates in the tumor microenvironment and worse clinical outcome. Utilizing the molecular pathological epidemiology resources of 795 rectal and colon cancers in two U.S.-nationwide prospective cohort studies, we measured tumor-associated let-7a and let-7b expression levels by quantitative reverse-transcription PCR, and CD3+, CD8+, CD45RO (PTPRC)+, and FOXP3+ cell densities by tumor tissue microarray immunohistochemistry and computer-assisted image analysis. Logistic regression analysis and Cox proportional hazards regression were used to assess associations of let-7a (and let-7b) expression (quartile predictor variables) with T-cell densities (binary outcome variables) and mortality, respectively, controlling for tumor molecular features, including microsatellite instability, CpG island methylator phenotype, LINE-1 methylation, and KRAS, BRAF, and PIK3CA mutations. Compared with cases in the lowest quartile of let-7a expression, those in the highest quartile were associated with lower densities of CD3+ [multivariate odds ratio (OR), 0.40; 95% confidence interval (CI), 0.23-0.67; Ptrend = 0.003] and CD45RO+ cells (multivariate OR, 0.31; 95% CI, 0.17-0.58; Ptrend = 0.0004), and higher colorectal cancer-specific mortality (multivariate hazard ratio, 1.82; 95% CI, 1.42-3.13; Ptrend = 0.001). In contrast, let-7b expression was not significantly associated with T-cell density or colorectal cancer prognosis. Our data support the role of let-7a in suppressing antitumor immunity in colorectal cancer and suggest let-7a as a potential target of immunotherapy.

AB - Experimental evidence suggests that the let-7 family of noncoding RNAs suppresses adaptive immune responses, contributing to immune evasion by the tumor. We hypothesized that the amount of let-7a and let-7b expression in colorectal carcinoma might be associated with limited T-lymphocyte infiltrates in the tumor microenvironment and worse clinical outcome. Utilizing the molecular pathological epidemiology resources of 795 rectal and colon cancers in two U.S.-nationwide prospective cohort studies, we measured tumor-associated let-7a and let-7b expression levels by quantitative reverse-transcription PCR, and CD3+, CD8+, CD45RO (PTPRC)+, and FOXP3+ cell densities by tumor tissue microarray immunohistochemistry and computer-assisted image analysis. Logistic regression analysis and Cox proportional hazards regression were used to assess associations of let-7a (and let-7b) expression (quartile predictor variables) with T-cell densities (binary outcome variables) and mortality, respectively, controlling for tumor molecular features, including microsatellite instability, CpG island methylator phenotype, LINE-1 methylation, and KRAS, BRAF, and PIK3CA mutations. Compared with cases in the lowest quartile of let-7a expression, those in the highest quartile were associated with lower densities of CD3+ [multivariate odds ratio (OR), 0.40; 95% confidence interval (CI), 0.23-0.67; Ptrend = 0.003] and CD45RO+ cells (multivariate OR, 0.31; 95% CI, 0.17-0.58; Ptrend = 0.0004), and higher colorectal cancer-specific mortality (multivariate hazard ratio, 1.82; 95% CI, 1.42-3.13; Ptrend = 0.001). In contrast, let-7b expression was not significantly associated with T-cell density or colorectal cancer prognosis. Our data support the role of let-7a in suppressing antitumor immunity in colorectal cancer and suggest let-7a as a potential target of immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=85016117736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016117736&partnerID=8YFLogxK

U2 - 10.1158/2326-6066.CIR-16-0112

DO - 10.1158/2326-6066.CIR-16-0112

M3 - Article

C2 - 27737877

AN - SCOPUS:85016117736

VL - 4

SP - 927

EP - 935

JO - Cancer immunology research

JF - Cancer immunology research

SN - 2326-6066

IS - 11

ER -